PRF Technologies PRFX
NASDAQ PRFX
$0.93 -0.03 (-3.23%)
At close: Sep 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Accounts Payables (2019 - 2026)

PRF Technologies' (PRFX) quarterly Accounts Payables came in at $182000.0 in Q2 2026, up 13.75% on a YoY basis from $160000.0 in Q2 2025, and down 14.55% quarter-over-quarter from $213000.0 in Q4 2025.

Analysis

PRF Technologies (PRFX) Accounts Payables (2019 - 2026) Analysis & Trends

PRF Technologies (PRFX) has reported Accounts Payables for 8 consecutive years, with $182000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accounts Payables rose 13.75% year-over-year to $182000.0; the trailing twelve-month figure through Jun 2026 stood at $182000.0 (up 13.75% YoY), and the FY2025 full-year result was $213000.0, down 28.04% from the prior year.
  • Accounts Payables slipped to $182000.0 in Q2 2026 per PRFX's latest filing, from $213000.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $385000.0 in Q3 2022 and bottomed at $69000.0 in Q4 2023.
  • Historically, Accounts Payables has averaged $213214.3 across 5 years, with a median of $210500.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Accounts Payables slumped 66.99% in 2023, then soared 328.99% in 2024.
  • Over 5 years, Accounts Payables stood at $209000.0 in 2022, then plunged by 66.99% to $69000.0 in 2023, then jumped by 328.99% to $296000.0 in 2024, then slipped by 28.04% to $213000.0 in 2025, then declined by 14.55% to $182000.0 in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $182000.0, $213000.0, and $160000.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn 2.72 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 1.73 Bn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 396.07 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn 721.21 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 593.00 Mn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 73.83 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn 133.16 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 251.37 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn 5.52 Mn
10 PRF Technologies 622,054.07 -10.31 Mn - 182,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 182,000.00
Dec 31, 2025 213,000.00
Jun 30, 2025 160,000.00
Dec 31, 2024 296,000.00
Jun 30, 2024 119,000.00
Mar 31, 2024 209,000.00
Dec 31, 2023 69,000.00
Sep 30, 2023 214,000.00
Jun 30, 2023 70,000.00
Mar 31, 2023 313,000.00
Dec 31, 2022 209,000.00
Sep 30, 2022 385,000.00
Jun 30, 2022 212,000.00
Mar 31, 2022 334,000.00
Dec 31, 2021 136,000.00
Sep 30, 2021 171,000.00
Jun 30, 2021 57,000.00
Mar 31, 2021 159,000.00
Dec 31, 2020 720,000.00
Jun 30, 2020 13,000.00
API Access

PRF Technologies Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=PRFX&period=max&api_key=YOUR_API_KEY